Immunization and Infectious Disease Update
National Association of County & City Health Officials
Information and Resources for Local Health Departments |
| Resources | |
Resources for Preventing Infections in Cancer Patients
Ongoing outbreaks resulting from unsafe injection practices in outpatient oncology settings have highlighted the role of health departments in investigating, responding to, and preventing such infections. The Centers for Disease Control and Prevention (CDC), through the Preventing Infections in Cancer Patients program, has developed the following resources that local health departments can share with health care providers, patients, and care givers to help reduce the risk of developing potentially life-threatening infections during chemotherapy treatment:
Please email NACCHO for additional key messages to support your agency's education and outreach activities.
Updated Meningococcal Vaccine Information Statement
The CDC's Meningococcal vaccine information statement has recently been updated and is now available. This VIS includes updates in contraindication, precaution, and adverse event information, and thus, its use should begin immediately. FDA Statement on Jet Injector Vaccines FDA has recently received questions regarding the use of jet injector devices to administer inactivated influenza vaccines. Currently, there is only one vaccine, Measles, Mumps and Rubella (MMR), that is approved and specifically labeled for administration by jet injector. At this time, there are no inactivated influenza vaccines that are approved and specifically labeled by the FDA for administration by jet injector. Read the FDA statement.
ACIP Recommends 11-12 Year-Old Males Get HPV Vaccine
The Advisory Committee on Immunization Practices (ACIP) recently took another step in the battle against HPV, a leading cause of various sexually transmitted diseases, as well as certain forms of cancers, by recommending vaccination of males. A transcript of the press conference announcing this, with the rationale behind this decision, can be accessed online. Zombie Pandemic Graphic Novel Check out Preparedness 101: Zombie Pandemic, the Office for Public Health Preparedness and Response's graphic novel, which introduces the importance of preparedness in a creative new format. CDC Statement on Results from Malaria Vaccine Trial The CDC recently announced results from the clinical trial in Africa of a malaria vaccine candidate. These results show that the vaccine prevented about half of malaria cases, including the most severe, in young children. Learn more. |
Get Involved
| |
Webinar: Effective Strategies to Promote Influenza Vaccine Uptake Among Culturally Diverse Populations
Leading experts in vaccine safety and health care disparities at federal agencies and health plans will discuss the best practices at the local, regional and national level necessary to improve immunization rates among diverse groups especially among Hispanic/Latinos and African Americans. The webinar will be held Thursday, Nov. 10, from 1-2:30 PM EST.
2012 Model Practice Submissions
NACCHO will accept model practice applications October 10 through November 11, 2011. Since 2003, NACCHO's Model Practice Awards program has honored innovative LHD programs. If you have any questions concerning the Model Practice program please e-mail practices@naccho.org and a member of NACCHO membership team will respond. For more information, visit NACCHO's website.
Become an ACHIEVE Community
NACCHO recently released a request for applications for ACHIEVE (Action Communities for Health, Innovation, and EnVironmental changE). The 2012 ACHIEVE initiative will include an emphasis on peer mentoring. Three new communities (mentees) and three current ACHIEVE communities (mentors) will be selected, for a total of six funded communities. Both potential applicants must submit a joint application. For more information, please visit the ACHIEVE website.
Submit a Tool to NACCHO's Immunization and Infectious Disease Toolkits
NACCHO's Immunization and Infectious Disease Toolkits are intended to provide local health departments (LHDs) with resources related to immunization and infectious disease prevention and control practices. Examples of tools include templates, guides, community resources and much more. Log in to submit your own resources to the Toolkit to share with other LHDs.
|
Publications
| | |
Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months --- Advisory Committee on Immunization Practices (ACIP)
Centers for Disease Control and Prevention. (2011). Morbidity and Mortality Weekly Report, 60(41):1424-6.
Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline
Davis MM, Butchart AT, Wheeler JR, Coleman MS, Singer DC, Freed GL. (2011). Vaccine (e-pub ahead of print).
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009
Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, Gershman K, Yousey-Hindes K, Arnold K, Ryan P, Lynfield R, Morin C, Baumbach J, Hancock EB, Bennett NM, Zansky S, Thomas A, Schaffner W, Fry AM. (2011). J Infect Dis. (e-pub ahead of print).
Lessons from the US rotavirus vaccination program
Glass RI, Patel M, Parashar U. (2011). JAMA, 306(15):1701-2.
Salmonella infections associated with international travel: A Foodborne Diseases Active Surveillance Network (FoodNet) study
Johnson LR, Gould LH, Dunn JR, Berkelman R, Mahon BE. (2011). Foodborne Pathog Dis. 8(9):1031-7.
Balancing vaccine science and national policy objectives: Lessons from the National Vaccine Injury Compensation Program Omnibus Autism Proceedings
Keelan J, Wilson K. (2011). Am J Public Health, 101(11):2016-21.
Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment
Kurbatova EV, Gammino VM, Bayona J, Becerra M, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP. (2011). Int J Tuberc Lung Dis, 15(11):1553-6.
IMP-producing carbapenem resistant Klebsiella pneumoniae in the United States
Limbago BM, Rasheed JK, Anderson KF, Zhu W, Kitchel B, Watz N, Munro S, Gans H, Banaei N, Kallen AJ. (2011). J Clin Microbiol. (e-pub ahead of print).
Evidence used to support the achievement and maintenance of elimination of rubella and congenital rubella syndrome in the United States
Reef SE, Redd SB, Abernathy E, Kutty P, Icenogle JP. (2011). J Infect Dis. 204 Suppl 2:S593-7.
Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral
Thomas JD, Jackson ML, Sharma D, Mair R, Bach MC, Castillo D, Ejigiri OG, Satola S, Cohn AC, Jerris R, Jain S, Farley MM, Mayer LW, Messonnier NE. (2011). Clin Vaccine Immunol. (e-pub ahead of print).
|
|
NACCHO is the national organization representing local health departments. NACCHO works to support efforts that protect and improve the health of all people and all communities by promoting national policy, developing resources and programs, seeking health equity and supporting effective local public health practice and systems.
For additional information about NACCHO, visit: www.naccho.org. |
|
|
|
|
|
